BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V} Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V}

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (298)	3/14/2000 8:15:00 PM
From: BRAVEHEART	Read Replies (1) of 423

Hi Tuck, I suppose that was DRAX @ 3 1/8th. DRAX has a strong presence in Canada. Granted not as big a market as the US if you understand their business plan it shows significant leverage with reduced competition. Check out the recent news developments. If DRAX keeps rolling out these inlicensed drugs it will only add to it's overall valuation. Only the third product of eight has been launched. They hired a pr IBF back in Nov. We have only seen 1/3 of the story in my guesstimate. Once we get through $5 then $7 should be within reach. finance.yahoo.com The company has four major niche market divisions & significant partners. With 29% revenue growth over the past nine months. biz.yahoo.com Jeffrey

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next